Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment

Int J Nanomedicine. 2021 Sep 3:16:6141-6156. doi: 10.2147/IJN.S311248. eCollection 2021.

Abstract

At present, some bacteria have developed significant resistance to almost all available antibiotics. One of the reasons that cannot be ignored is long-term exposure of bacteria to the sub-minimum inhibitory concentration (MIC) of antibiotics. Therefore, it is necessary to develop a targeted antibiotic delivery system to improve drug delivery behavior, in order to delay the generation of bacterial drug resistance. In recent years, with the continuous development of nanotechnology, various types of nanocarriers that respond to the infection microenvironment, targeting specific bacterial targets, and targeting infected cells, and so on, are gradually being used in the delivery of antibacterial agents to increase the concentration of drugs at the site of infection and reduce the side effects of drugs in normal tissues. Here, this article describes in detail the latest research progress on nanocarriers for antimicrobial, and commonly used targeted antimicrobial strategies. The advantages of the combination of nanotechnology and targeting strategies in combating bacterial infections are highlighted in this review, and the upcoming opportunities and remaining challenges in this field are rationally prospected.

Keywords: antimicrobial; drug delivery; nanocarriers; targeting strategies.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents* / therapeutic use
  • Bacterial Infections* / drug therapy
  • Drug Delivery Systems
  • Drug Resistance, Bacterial
  • Humans

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents